Structures by: Ngah N.
Total: 28
2-[3-(4-Methoxybenzoyl)thioureido]-3-methylbutyric acid
C14H18N2O4S
Acta Crystallographica Section E (2006) 62, 5 o1903-o1904
a=8.0510(10)Å b=8.0840(10)Å c=13.205(2)Å
α=83.741(2)° β=80.164(3)° γ=66.162(2)°
(9S)-2-(3-Benzoylthioureido)-3-(1H-imidazol-4-yl)propionic acid
C14H14N4O3S
Acta Crystallographica Section E (2005) 61, 6 o1689-o1691
a=5.6995(13)Å b=17.916(4)Å c=7.0525(17)Å
α=90.00° β=99.424(5)° γ=90.00°
N-[3-(Hydroxymethyl)phenyl]-N'-(4-methoxybenzoyl)thiourea
C16H16N2O3S
Acta Crystallographica Section E (2005) 61, 4 o1018-o1019
a=17.559(7)Å b=8.959(4)Å c=19.566(8)Å
α=90.00° β=97.591(9)° γ=90.00°
2-(3-Benzoylthioureido)ethanoic acid dimethyl sulfoxide solvate
C10H10N2O3S,C2H6OS
Acta Crystallographica Section E (2005) 61, 6 o1910-o1912
a=10.074(2)Å b=5.6289(12)Å c=13.969(3)Å
α=90.00° β=110.074(4)° γ=90.00°
(9S)-2-(3-Benzoylthioureido)-3-methylbutyric acid
C13H16N2O3S
Acta Crystallographica Section E (2005) 61, 6 o1767-o1768
a=5.2223(13)Å b=11.781(3)Å c=22.738(5)Å
α=90.00° β=90.00° γ=90.00°
2-[3-(4-Methoxybenzoyl)thiouredo]-3-phenylpropionic acid methanol solvate
C18H18N2O4S,CH4O
Acta Crystallographica Section E (2005) 61, 12 o4307-o4309
a=5.0364(13)Å b=16.716(4)Å c=23.040(6)Å
α=90.00° β=90.00° γ=90.00°
3-(1H-Indol-3-yl)-2-[3-(4-methoxybenzoyl)thioureido]propionic acid
C20H19N3O4S
Acta Crystallographica Section E (2006) 62, 3 o1025-o1027
a=18.247(4)Å b=14.083(3)Å c=14.736(3)Å
α=90.00° β=90.00° γ=90.00°
Bis(2,3-dibromo-6,7,9,10,12,13,15,16-octahydro-5,8,11,14,17-pentaoxa- benzocyclopentadecene)hydroxonium tribromide
2C14H18Br2O5,H3O,Br3
Acta Crystallographica Section E (2006) 62, 4 o1654-o1656
a=12.568(3)Å b=13.590(3)Å c=13.829(3)Å
α=70.697(4)° β=66.718(4)° γ=67.601(4)°
1-benzoyl-3-(6-methylpyridin-2-yl)thiourea
C14H13N3OS
Acta Crystallographica Section E (2006) 62, 4 o1446-o1448
a=7.2687(14)Å b=18.938(4)Å c=10.1216(19)Å
α=90.00° β=109.756(4)° γ=90.00°
3-[3-(4-methoxybenzoyl)thioureido]propionic acid
C12H14N2O4S
Acta Crystallographica Section E (2006) 62, 8 o3369-o3371
a=9.795(3)Å b=4.7790(13)Å c=14.951(4)Å
α=90.00° β=108.275(5)° γ=90.00°
Fe^III^(Salpn)(μ~2~-Salpn)Fe^III^(Salpn)
C51H48Fe2N6O6
Acta Crystallographica Section E (2005) 61, 8 m1464-m1466
a=24.463(4)Å b=14.818(2)Å c=15.911(3)Å
α=90.00° β=121.138(2)° γ=90.00°
2-(3-Benzoylthioureido)propionic acid
C11H12N2O3S
Acta Crystallographica Section E (2006) 62, 1 o381-o382
a=7.3570(18)Å b=8.083(2)Å c=10.706(3)Å
α=87.395(4)° β=77.128(4)° γ=72.065(5)°
Isocrotocaudin
C19H18O5
Acta Crystallographica Section E (2005) 61, 4 o1035-o1037
a=6.677(2)Å b=10.794(3)Å c=22.608(7)Å
α=90.00° β=90.00° γ=90.00°
1-(2-Hydroxyphenyl)ethanone benzoylhydrazone
C15H14N2O2
Acta Crystallographica Section E (2005) 61, 4 o969-o970
a=4.9110(18)Å b=12.466(4)Å c=21.018(7)Å
α=90.00° β=91.299(6)° γ=90.00°
(2S)-1-(Benzoylthiocarbamoyl)pyrrolidine-2-carboxylic acid monohydrate
C13H14N2O3S,H2O
Acta Crystallographica Section E (2006) 62, 10 o4501-o4502
a=9.05(4)Å b=12.00(6)Å c=13.33(6)Å
α=90.00° β=90.00° γ=90.00°
<i>N</i>-Benzoyl-<i>N</i>'-(3-hydroxyphenyl)thiourea
C14H12N2O2S
Acta Crystallographica Section E (2007) 63, 5 o2403-o2404
a=12.209(3)Å b=7.3126(17)Å c=15.710(4)Å
α=90.00° β=112.133(4)° γ=90.00°
Ethyl 1-<i>sec</i>-butyl-2-(4-fluorophenyl)-1<i>H</i>-benzimidazole- 5-carboxylate
C20H21FN2O2
Acta Crystallographica Section E (2011) 67, 11 o2938
a=10.2249(16)Å b=12.3767(18)Å c=14.149(2)Å
α=90.00° β=93.473(2)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-(4-methoxyphenyl)-1<i>H</i>-benzimidazole- 5-carboxylate monohydrate
C19H20N2O4,H2O
Acta Crystallographica Section E (2012) 68, 2 o421
a=10.6364(11)Å b=9.5089(10)Å c=19.3765(17)Å
α=90.00° β=112.899(5)° γ=90.00°
3-[3-(2-Fluorobenzoyl)thioureido]propionic acid
C11H11FN2O3S
Acta Crystallographica Section E (2014) 70, 6 o705
a=11.7103(7)Å b=11.1289(7)Å c=9.6760(7)Å
α=90.00° β=108.407(2)° γ=90.00°
1-(4-Chlorobutanoyl)-3-(2-nitrophenyl)thiourea
C11H12ClN3O3S
Acta Crystallographica Section E (2012) 68, 6 o1801
a=14.593(4)Å b=11.288(3)Å c=17.828(5)Å
α=90.00° β=110.765(5)° γ=90.00°
Ethyl 2-(4-bromophenyl)-1-<i>sec</i>-butyl-1<i>H</i>-benzimidazole-5-carboxylate
C20H21BrN2O2
Acta Crystallographica Section E (2011) 67, 12 o3453
a=10.5187(2)Å b=12.7525(2)Å c=13.7444(2)Å
α=90.00° β=98.1010(10)° γ=90.00°
1-(4-Chlorobutanoyl)-3-(2-chlorophenyl)thiourea
C11H12Cl2N2OS
Acta Crystallographica Section E (2012) 68, 5 o1536
a=14.396(3)Å b=10.941(2)Å c=18.093(4)Å
α=90.00° β=109.399(4)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-propyl-1<i>H</i>-benzimidazole-5-carboxylate
C15H20N2O3
Acta Crystallographica Section E (2011) 67, 10 o2704
a=8.5081(3)Å b=8.5573(3)Å c=10.0117(4)Å
α=94.671(3)° β=106.903(2)° γ=98.334(3)°
Ethyl 1-(butan-2-yl)-2-(2-methoxyphenyl)-1<i>H</i>-benzimidazole-5-carboxylate
C21H24N2O3
Acta Crystallographica Section E (2011) 67, 12 o3231-o3232
a=10.6746(3)Å b=12.3344(4)Å c=15.6158(5)Å
α=90.00° β=106.9010(10)° γ=90.00°
Ethyl 1-(2-hydroxyethyl)-2-[2-(methylsulfanyl)ethyl]- 1<i>H</i>-benzimidazole-5-carboxylate
C15H20N2O3S
Acta Crystallographica Section E (2012) 68, 1 o197-o198
a=8.39090(10)Å b=8.8277(2)Å c=11.5025(2)Å
α=110.2180(10)° β=102.5290(10)° γ=99.1010(10)°
2-Bromo-4-(3,4-dimethyl-5-phenyl-1,3-oxazolidin-2-yl)-6-methoxyphenol
C18H20BrNO3
Acta Crystallographica Section E (2012) 68, 1 o35-o36
a=7.8056(4)Å b=11.9034(6)Å c=18.9109(9)Å
α=90.00° β=90.00° γ=90.00°
1-(Biphenyl-4-ylcarbonyl)-3-(2-chloro-4-nitrophenyl)thiourea
C20H14ClN3O3S
Acta Crystallographica Section E (2012) 68, 5 o1485
a=10.889(2)Å b=5.4502(10)Å c=30.532(5)Å
α=90.00° β=99.202(4)° γ=90.00°
2-<i>sec</i>-Butyl-1-(2-hydroxyethyl)-1<i>H</i>-benzimidazole-5-carboxylic acid
C14H18N2O3
Acta Crystallographica Section E (2012) 68, 7 o1995
a=8.9427(2)Å b=8.2067(2)Å c=18.3536(3)Å
α=90.00° β=94.4150(10)° γ=90.00°